sur SCOR (EPA:SCR)
SCOR validates its retrocession agreements with Covéa
On June 25, 2026, SCOR received confirmation from the arbitration tribunal on the validity of the retrocession agreements concluded with Covéa in June 2021. These agreements allow the transfer of 30% of SCOR's Life & Health portfolio to Covéa, based on the assets held as of December 31, 2020.
The court not only validated these agreements but also ruled that Covéa must be compensated with $488.3 million. After provisions, SCOR estimates that the impact on its second-quarter 2026 results will be approximately €50 million, while maintaining its solvency ratio and liquidity.
SCOR is focused on completing its Forward 2026 plan, with an emphasis on balance sheet resilience and underwriting discipline.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SCOR